呼吸器医学の進歩には 多分野間の協力が不可欠です ECM賞受賞者とのインタビュー2024
関連する実験動画
Updated: Sep 10, 2025
09:47
Isolation of CD146+ Resident Lung Mesenchymal Stromal Cells from Rat Lungs
Published on: June 17, 2016
8.4K
Emily Hume1,2, Viresh Jagesar3,2, Job F M van Boven4
1Department of Sport, Exercise and Rehabilitation, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Breathe (Sheffield, England)
|August 21, 2025
まとめ
ジョブ・ヴァン・ボヴェンは 呼吸器医学におけるコラボレーション,ビジョン,デジタル技術の重要性について語ります. 彼は欧州呼吸器学会を強調しています
科学分野:
- デジタル・ヘルス
- 呼吸器薬
- プロフェッショナル・開発
背景:
- 欧州呼吸器学会 (ERS) は デジタル・ヘルス・イニシアチブを調整する上で 重要な役割を果たしています
- 呼吸器医学の進歩には 効果的な協力とネットワークが不可欠です
- デジタル技術の未来に対する 明確なビジョンと理解は リーダーシップにとって不可欠です
研究 の 目的:
- 呼吸器医学における専門的な成長のための主要な戦略を概説する.
- デジタルヘルスの分野における ERS の役割を強調する.
- 医療従事者の仕事と生活のバランスを保つための洞察を提供するためです.
主な方法:
- 賞を受賞したリーダーからの 専門家の意見と洞察
- デジタルヘルスとテクノロジーの現在のトレンドを議論する.
- リーダーシップの原則と仕事と生活の統合の探求
主要な成果:
- 協力とネットワーク構築は成功の基本です
- テクノロジーの進歩を把握するには 未来を考えるビジョンが不可欠です
- ERSはデジタルヘルス導入の 中心的なファシリテーターとして位置づけられています.
- ワーク・ライフ・バランスは 戦略的計画によって達成できます
結論:
- デジタルトランスフォーメーションを受け入れることは 呼吸器の治療の未来にとって 鍵となるものです
- 強力な専門のネットワークは 研究と臨床実務を強化します
- 呼吸器医学におけるリーダーシップには ビジョン,協力,適応の組み合わせが必要です
さらに関連する動画
02:09Multi-modal Pulmonary Imaging: Using Complementary Information from CT and Hyperpolarized 129Xe MRI to Evaluate Lung Structure-Function
Published on: April 12, 2024
676
04:10Author Spotlight: Expanding Interventional Pulmonology Research with Robotic-Assisted Bronchoscopy
Published on: July 19, 2024
801
関連する概念動画
01:31Common Respiratory Disorders
909
Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
909
01:21Acute Respiratory Failure-II
360
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
360
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
01:30Acute Respiratory Failure-III
318
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
318
01:29Acute Respiratory Failure-V
205
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
205
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44